TSBP1
geneOn this page
Also known as TSBP
Summary
TSBP1 (testis expressed basic protein 1, HGNC:13922) is a protein-coding gene on chromosome 6p21.32, encoding Testis-expressed basic protein 1 (Q5SRN2).
Located in nucleus.
Source: NCBI Gene 10665 — RefSeq curated summary.
At a glance
- GWAS associations: 137
- Clinical variants (ClinVar): 6 total
- MANE Select transcript:
NM_001286474
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13922 |
| Approved symbol | TSBP1 |
| Name | testis expressed basic protein 1 |
| Location | 6p21.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TSBP |
| Ensembl gene | ENSG00000204296 |
| Ensembl biotype | protein_coding |
| OMIM | 618151 |
| Entrez | 10665 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 protein_coding
ENST00000375015, ENST00000442822, ENST00000447241, ENST00000527965, ENST00000532023, ENST00000533191, ENST00000534588, ENST00000698834
RefSeq mRNA: 3 — MANE Select: NM_001286474
NM_001286474, NM_001286475, NM_006781
CCDS: CCDS34422, CCDS69082, CCDS75430
Canonical transcript exons
ENST00000413045 — 0 exons
Expression profiles
Bgee: expression breadth broad, 58 present calls, max score 89.77.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0437 / max 33.8314, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 72945 | 0.0244 | 3 |
| 72946 | 0.0134 | 3 |
| 72944 | 0.0059 | 3 |
Top tissues by expression
94 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 89.77 | gold quality |
| testis | UBERON:0000473 | 89.33 | gold quality |
| right testis | UBERON:0004534 | 88.88 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.10 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.51 | gold quality |
| sural nerve | UBERON:0015488 | 55.74 | gold quality |
| lymph node | UBERON:0000029 | 52.50 | gold quality |
| bone marrow cell | CL:0002092 | 47.96 | gold quality |
| colonic epithelium | UBERON:0000397 | 46.68 | gold quality |
| calcaneal tendon | UBERON:0003701 | 46.04 | silver quality |
| adrenal tissue | UBERON:0018303 | 45.37 | gold quality |
| tonsil | UBERON:0002372 | 44.36 | silver quality |
| uterine cervix | UBERON:0000002 | 42.99 | silver quality |
| right ovary | UBERON:0002118 | 42.45 | silver quality |
| ventricular zone | UBERON:0003053 | 42.31 | gold quality |
| ovary | UBERON:0000992 | 41.35 | gold quality |
| cortical plate | UBERON:0005343 | 41.27 | gold quality |
| endometrium | UBERON:0001295 | 40.74 | gold quality |
| left ovary | UBERON:0002119 | 39.71 | gold quality |
| endocervix | UBERON:0000458 | 39.43 | gold quality |
| ganglionic eminence | UBERON:0004023 | 39.03 | gold quality |
| bone marrow | UBERON:0002371 | 38.91 | gold quality |
| body of uterus | UBERON:0009853 | 38.12 | silver quality |
| metanephros cortex | UBERON:0010533 | 35.71 | silver quality |
| apex of heart | UBERON:0002098 | 35.45 | gold quality |
| ectocervix | UBERON:0012249 | 35.24 | silver quality |
| tibial nerve | UBERON:0001323 | 35.13 | gold quality |
| vermiform appendix | UBERON:0001154 | 35.12 | gold quality |
| granulocyte | CL:0000094 | 34.99 | gold quality |
| duodenum | UBERON:0002114 | 34.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.41 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting TSBP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-4679 | 99.76 | 69.19 | 1229 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-4738-3P | 98.98 | 67.98 | 1846 |
| HSA-MIR-6761-5P | 98.71 | 68.03 | 1504 |
| HSA-MIR-6830-3P | 98.62 | 68.07 | 1760 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-3689A-5P | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689B-5P | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689E | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689F | 98.35 | 70.08 | 1052 |
| HSA-MIR-5087 | 98.01 | 69.09 | 965 |
| HSA-MIR-4468 | 98.01 | 66.85 | 1187 |
| HSA-MIR-5681A | 97.99 | 67.17 | 1658 |
| HSA-MIR-15B-3P | 97.85 | 66.68 | 974 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-6500-3P | 97.42 | 67.20 | 867 |
| HSA-MIR-2278 | 97.30 | 66.19 | 1130 |
| HSA-MIR-4474-3P | 96.97 | 65.87 | 870 |
Literature-anchored findings (GeneRIF, showing 4)
- Our findings suggest that CpG-single nucleotide polymorphisms at the C6orf10/LOC101929163 locus might modify age of onset in C9orf72 carriers belonging to the entire amyotrophic lateral sclerosis-frontotemporal dementia spectrum by controlling DNA methylation and gene expression (PMID:30252044)
- Shared Signature of Recent Positive Selection on the TSBP1-BTNL2-HLA-DRA Genes in Five Native Populations from North Borneo. (PMID:33022050)
- Multilocus evaluation of genetic predictors of multiple sclerosis. (PMID:34656742)
- Impact of missense TSBP1 variants on the susceptibility to coronary heart disease. (PMID:38042215)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tsbp1 | ENSMUSG00000057246 |
| rattus_norvegicus | Tsbp1 | ENSRNOG00000039398 |
Protein
Protein identifiers
Testis-expressed basic protein 1 — Q5SRN2 (reviewed: Q5SRN2)
Alternative names: Uncharacterized protein C6orf10
All UniProt accessions (7): A0A1U9X7D1, A0A8V8TNR9, C9J9T8, E9PLW3, E9PNQ4, E9PQ85, Q5SRN2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5SRN2-1 | 1 | yes |
| Q5SRN2-2 | 2 | |
| Q5SRN2-3 | 3 |
RefSeq proteins (3): NP_001273403, NP_001273404, NP_006772 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038754 | TSBP1 | Family |
UniProt features (28 total): sequence variant 14, compositionally biased region 5, splice variant 4, transmembrane region 2, region of interest 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5SRN2-F1 | 45.58 | 0.04 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 33 (showing top):
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM, KRAS.600.LUNG.BREAST_UP.V1_DN, KRAS.BREAST_UP.V1_DN, KRAS.LUNG.BREAST_UP.V1_DN, ZNF146_TARGET_GENES, MIR4505, MIR5787, MIR5681A, FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON, TTCYRGAA_UNKNOWN, DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS, FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN, GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN, GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN, GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): nucleus (GO:0005634), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
354 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TSBP1 | BTNL2 | Q9UIR0 | 697 |
| TSBP1 | TTC32 | Q5I0X7 | 591 |
| TSBP1 | MICB | P79525 | 539 |
| TSBP1 | COL11A2 | P13942 | 531 |
| TSBP1 | NOTCH4 | Q99466 | 527 |
| TSBP1 | HLA-DRA | P01903 | 507 |
| TSBP1 | HLA-DRB1 | P01911 | 505 |
| TSBP1 | HLA-DQB1 | P01917 | 479 |
| TSBP1 | PSORS1C1 | Q9UIG5 | 471 |
| TSBP1 | E7ENX8 | E7ENX8 | 448 |
| TSBP1 | Q5Y7H0 | Q5Y7H0 | 446 |
| TSBP1 | TNF | P01375 | 432 |
| TSBP1 | BRD2 | P25440 | 429 |
| TSBP1 | RNF5 | Q99942 | 417 |
| TSBP1 | TNXB | P22105 | 417 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARHGAP18 | CLTB | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): C6orf10 (Biochemical Activity), C6orf10 (Affinity Capture-MS), C6orf10 (Cross-Linking-MS (XL-MS)), C6orf10 (Cross-Linking-MS (XL-MS)), C6orf10 (Affinity Capture-MS), C6orf10 (Proximity Label-MS)
ESM2 similar proteins: A0A060XQP6, A0A1S4FQ37, A2VD23, A3KQQ9, A7E371, B3A0Q3, B3EWZ0, B3EWZ1, B3EWZ4, B7W112, D1FQ14, E9Q9K5, G5EC21, O01949, O16883, O43493, O46203, O55188, O84462, P08721, P10451, P10923, P13665, P14287, P19814, P23498, P31096, P31097, P31098, P31936, P35662, P35663, P98193, Q13316, Q14093, Q28139, Q5MIT9, Q5SRN2, Q5UQ32, Q62313
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2509 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:32335910:A:AC | donor_gain | 1.0000 |
| 6:32335911:C:CC | donor_gain | 1.0000 |
| 6:32337187:T:TA | donor_gain | 1.0000 |
| 6:32300701:C:CC | acceptor_gain | 0.9900 |
| 6:32302607:A:AC | donor_gain | 0.9900 |
| 6:32302608:C:CC | donor_gain | 0.9900 |
| 6:32302628:TCCTG:T | acceptor_loss | 0.9900 |
| 6:32302629:CCTGA:C | acceptor_loss | 0.9900 |
| 6:32302630:CTG:C | acceptor_loss | 0.9900 |
| 6:32331958:TAA:T | donor_gain | 0.9900 |
| 6:32331959:AAA:A | donor_gain | 0.9900 |
| 6:32331960:A:C | donor_gain | 0.9900 |
| 6:32335933:C:CC | acceptor_gain | 0.9900 |
| 6:32355648:C:CT | donor_gain | 0.9900 |
| 6:32300678:A:AC | donor_gain | 0.9800 |
| 6:32300679:C:CC | donor_gain | 0.9800 |
| 6:32302608:CTA:C | donor_gain | 0.9800 |
| 6:32302631:T:A | acceptor_loss | 0.9800 |
| 6:32331959:A:AC | donor_gain | 0.9800 |
| 6:32335907:CT:C | donor_loss | 0.9800 |
| 6:32335908:TT:T | donor_loss | 0.9800 |
| 6:32335911:C:CT | donor_loss | 0.9800 |
| 6:32355647:A:AC | donor_gain | 0.9800 |
| 6:32369896:CCA:C | donor_gain | 0.9800 |
| 6:32302608:CTAG:C | donor_gain | 0.9700 |
| 6:32335933:CTGTG:C | acceptor_loss | 0.9700 |
| 6:32335934:T:G | acceptor_loss | 0.9700 |
| 6:32335935:G:C | acceptor_gain | 0.9700 |
| 6:32335935:G:GC | acceptor_gain | 0.9700 |
| 6:32355678:A:C | acceptor_gain | 0.9700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000007662 (6:32351023 T>A,C), RS1000067287 (6:32321111 G>GT), RS1000078036 (6:32371552 A>G), RS1000129903 (6:32371298 C>T), RS1000132775 (6:32334966 G>A), RS1000138973 (6:32322811 C>T), RS1000144699 (6:32350561 G>T), RS1000184669 (6:32332383 A>G), RS1000329283 (6:32342630 A>G), RS1000381928 (6:32342351 C>T), RS1000420138 (6:32320830 C>T), RS1000440099 (6:32335267 A>G), RS1000492815 (6:32309701 G>T), RS1000602977 (6:32297980 T>A), RS1000659344 (6:32348647 C>G)
Disease associations
OMIM: gene MIM:618151 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
137 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000180_4 | Bone mineral density (spine) | 1.000000e-07 |
| GCST000408_6 | Primary biliary cholangitis | 1.000000e-10 |
| GCST000408_7 | Primary biliary cholangitis | 7.000000e-10 |
| GCST000624_3 | Ulcerative colitis | 9.000000e-23 |
| GCST000981_1 | Vitiligo | 8.000000e-11 |
| GCST000984_17 | Idiopathic membranous nephropathy | 2.000000e-40 |
| GCST000984_4 | Idiopathic membranous nephropathy | 5.000000e-71 |
| GCST000996_22 | Systemic lupus erythematosus | 3.000000e-06 |
| GCST001183_6 | Asthma | 3.000000e-15 |
| GCST001459_1 | Multiple sclerosis | 7.000000e-16 |
| GCST001525_5 | Visceral fat | 3.000000e-06 |
| GCST001574_8 | Activated partial thromboplastin time | 7.000000e-07 |
| GCST001587_6 | Coronary heart disease | 3.000000e-15 |
| GCST001709_7 | Atopic dermatitis | 5.000000e-19 |
| GCST001762_369 | Obesity-related traits | 2.000000e-06 |
| GCST001815_1 | Hepatitis C induced liver cirrhosis | 9.000000e-11 |
| GCST001942_21 | Prostate cancer | 5.000000e-09 |
| GCST002097_4 | Coronary artery calcification | 3.000000e-06 |
| GCST002217_4 | Sjögren’s syndrome | 9.000000e-37 |
| GCST002297_1 | Hepatitis B vaccine response | 3.000000e-19 |
| GCST002300_1 | Rheumatoid arthritis | 3.000000e-12 |
| GCST002479_16 | Lupus nephritis in systemic lupus erythematosus | 2.000000e-06 |
| GCST002737_3 | Atopic dermatitis | 4.000000e-08 |
| GCST003450_2 | Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia | 3.000000e-09 |
| GCST003773_15 | Loneliness (multivariate analysis) | 2.000000e-06 |
| GCST004122_3 | Fibrinogen levels | 9.000000e-09 |
| GCST004131_25 | Inflammatory bowel disease | 2.000000e-31 |
| GCST004133_79 | Ulcerative colitis | 5.000000e-65 |
| GCST004521_1 | Autism spectrum disorder or schizophrenia | 2.000000e-16 |
| GCST004521_10 | Autism spectrum disorder or schizophrenia | 2.000000e-13 |
EFO canonical traits (19, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004267 | biliary liver cirrhosis |
| EFO:0003939 | energy intake |
| EFO:0004723 | coronary artery calcification |
| EFO:0004645 | response to vaccine |
| EFO:0007865 | loneliness measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008002 | physical activity measurement |
| EFO:0007986 | reticulocyte count |
| EFO:0004587 | lymphocyte count |
| EFO:0008377 | mosquito bite reaction itch intensity measurement |
| EFO:0008378 | mosquito bite reaction size measurement |
| EFO:0009180 | rosacea severity measurement |
| EFO:0004808 | L lactate dehydrogenase measurement |
| EFO:0006336 | diastolic blood pressure |
| EFO:0004509 | hemoglobin measurement |
| EFO:0009819 | comparative body size at age 10, self-reported |
| EFO:0004918 | age at diagnosis |
| EFO:0008039 | BMI-adjusted hip circumference |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Silicon Dioxide | decreases expression | 2 |
| bisphenol A | affects methylation | 1 |
| butyraldehyde | decreases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): allergic disease, atopic eczema, chronic obstructive pulmonary disease, hepatitis C induced liver cirrhosis, Hodgkin’s lymphoma, mixed cellularity, Kawasaki disease, lung carcinoma, lupus nephritis, membranous glomerulonephritis, multiple sclerosis, rheumatoid arthritis, sarcoidosis, Sjogren syndrome, squamous cell lung carcinoma, Takayasu arteritis, type 1 diabetes mellitus, vitiligo